Scientists launch international registry to crack the code of ultra-rare cancer EHE
NCT ID NCT06408441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study creates a registry to collect information from 100 adults newly diagnosed with epithelioid hemangioendothelioma (EHE), an ultra-rare sarcoma. Researchers will track patients over time to understand how the disease progresses, what factors affect outcomes, and which treatments are used. The goal is to improve knowledge and care for this rare cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIOID HEMANGIOENDOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, Aarhus, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Azienda Ospedaliera Universitaria San Luigi Gonzaga
RECRUITINGOrbassano, Torino, 10043, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Azienda Ospedaliero Universitaria Careggi
RECRUITINGCareggi, Firenze, 50134, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Campus Großhadern
NOT_YET_RECRUITINGMünchen, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Oscar Lambret
NOT_YET_RECRUITINGLille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Essen University Hospital
RECRUITINGEssen, Hesse, 45147, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, Milan, 20133, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Fundación Jiménez Díaz
RECRUITINGMadrid, Madrid, 28040, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
IRCCS Istituto Clinica Humanitas
RECRUITINGRozzano, Milano, 20089, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Instituto Português Oncologia do Porto Francisco Gentil
NOT_YET_RECRUITINGPorto, Portugal
Contact Email: •••••@•••••
-
Istituto Nazionale dei Tumori Regina Elena
RECRUITINGRoma, Roma, 00144, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Oncologico Veneto
RECRUITINGPadova, Padova, 35128, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Ortopedico Rizzoli
RECRUITINGBologna, Bologna, 40136, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Léon Bérard Center
RECRUITINGLyon, Lyon, 69008, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Maria Skłodowska-Curie Institute of Oncology
RECRUITINGWarsaw, Warsaw, 00-001, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nuovo Ospedale di Prato "S.Stefano"
RECRUITINGPrato, Prato, 59100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Policlinico Universitario P. Giaccone
RECRUITINGPalermo, Palermo, 90127, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, Göteborg, 413 45, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Royal Marsden Hospital
RECRUITINGLondon, London, SW3 6JJ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Graz
RECRUITINGGraz, Graz, 8036, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Università Campus Bio-Medico
RECRUITINGRoma, Roma, 00128, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vall d'Hebron University Hospital
RECRUITINGBarcelona, Barcelona, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug targets rare cancer that often defies treatment
- Cancer-Killing virus injected directly into tumors shows promise in Mid-Stage trial
- New drug cocktail targets rare, aggressive cancer
- New drug combo shows promise for rare sarcoma
- New chemo combo shows promise for rare sarcoma
- New drug cocktail shows promise for rare sarcomas